Europe Intracranial Aneurysm Market Size, Share & Trends Analysis Report By End-use (Hospitals, Clinics, and Others), By Type (Endovascular Coiling, Flow Diverters, Surgical Clipping, and Others), By Country and Growth Forecast, 2023 - 2030

Europe Intracranial Aneurysm Market Size, Share & Trends Analysis Report By End-use (Hospitals, Clinics, and Others), By Type (Endovascular Coiling, Flow Diverters, Surgical Clipping, and Others), By Country and Growth Forecast, 2023 - 2030


The Europe Intracranial Aneurysm Market would witness market growth of 8.3% CAGR during the forecast period (2023-2030).

A portion of the skull is removed during craniotomy to gain access to the brain and execute neurosurgical interventions such as aneurysm coiling, clipping, or other intracranial procedures. Craniotomy provides direct access to the aneurysm site and allows neurosurgeons to perform precise surgical maneuvers while minimizing trauma to surrounding brain tissue.

The fundamental motivation behind the market is the pursuit of accuracy, which is propelled by developments in diagnostic imaging technologies that provide unparalleled visibility into the complex cerebral vasculature. Clinicians rely on digital subtraction angiography (DSA), computed tomography angiography (CTA), and magnetic resonance angiography (MRA) as indispensable instruments that enable them to navigate the complex networks of blood vessels and identify the elusive contributing factors responsible for these potential threats.

According to the Government of UK, from 2021 to 2022, 63.8% of adults aged 18 years and over in England were estimated to be overweight or living with obesity. This was an increase from 2020 to 2021 (63.3%). The prevalence of adults who are overweight or living with obesity varies by age in England, with adults aged between 45 and 84 years having a higher estimated prevalence than the England average. Likewise, according to the International Trade Administration (ITA), the medical device sector in France generated €36.7 billion in profit in 2022. It is estimated that medical device exports from France generate a market turnover of €9.4 billion, or 26% of the total market. Over the coming years, the industry is expected to expand by roughly 2% annually. Therefore, rising obesity and the growing medical devices industry in the region propel the market’s growth.

The Germany market dominated the Europe Intracranial Aneurysm Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $142.3 Million by 2030. The UK market is exhibiting a CAGR of 7.4% during (2023 - 2030). Additionally, The France market would experience a CAGR of 9.1% during (2023 - 2030).

Based on End-use, the market is segmented into Hospitals, Clinics, and Others. Based on Type, the market is segmented into Endovascular Coiling, Flow Diverters, Surgical Clipping, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

List of Key Companies Profiled
  • Medtronic PLC
  • Stryker Corporation
  • MicroPort Scientific Corporation
  • Johnson & Johnson
  • MicroVention, Inc. (Terumo Corporation)
  • B. Braun Melsungen AG
  • Integra LifeSciences Holdings Corporation
  • Delta Surgical
  • Penumbra, Inc.
Europe Intracranial Aneurysm Market Report Segmentation

By End-use
  • Hospitals
  • Clinics
  • Others
By Type
  • Endovascular Coiling
  • Flow Diverters
  • Surgical Clipping
  • Others
By Country
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe


Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Intracranial Aneurysm Market, by End-use
1.4.2 Europe Intracranial Aneurysm Market, by Type
1.4.3 Europe Intracranial Aneurysm Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter’s Five Forces Analysis
Chapter 4. Europe Intracranial Aneurysm Market by End-use
4.1 Europe Hospitals Market by Country
4.2 Europe Clinics Market by Country
4.3 Europe Others Market by Country
Chapter 5. Europe Intracranial Aneurysm Market by Type
5.1 Europe Endovascular Coiling Market by Country
5.2 Europe Flow Diverters Market by Country
5.3 Europe Surgical Clipping Market by Country
5.4 Europe Others Market by Country
Chapter 6. Europe Intracranial Aneurysm Market by Country
6.1 Germany Intracranial Aneurysm Market
6.1.1 Germany Intracranial Aneurysm Market by End-use
6.1.2 Germany Intracranial Aneurysm Market by Type
6.2 UK Intracranial Aneurysm Market
6.2.1 UK Intracranial Aneurysm Market by End-use
6.2.2 UK Intracranial Aneurysm Market by Type
6.3 France Intracranial Aneurysm Market
6.3.1 France Intracranial Aneurysm Market by End-use
6.3.2 France Intracranial Aneurysm Market by Type
6.4 Russia Intracranial Aneurysm Market
6.4.1 Russia Intracranial Aneurysm Market by End-use
6.4.2 Russia Intracranial Aneurysm Market by Type
6.5 Spain Intracranial Aneurysm Market
6.5.1 Spain Intracranial Aneurysm Market by End-use
6.5.2 Spain Intracranial Aneurysm Market by Type
6.6 Italy Intracranial Aneurysm Market
6.6.1 Italy Intracranial Aneurysm Market by End-use
6.6.2 Italy Intracranial Aneurysm Market by Type
6.7 Rest of Europe Intracranial Aneurysm Market
6.7.1 Rest of Europe Intracranial Aneurysm Market by End-use
6.7.2 Rest of Europe Intracranial Aneurysm Market by Type
Chapter 7. Company Profiles
7.1 MicroVention, Inc. (Terumo Corporation)
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expenses
7.1.5 Recent strategies and developments:
7.1.5.1 Trials and Approvals:
7.2 Medtronic PLC
7.2.1 Company overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expenses
7.2.5 Recent strategies and developments:
7.2.5.1 Product Launches and Product Expansions:
7.2.6 SWOT Analysis
7.3 Stryker Corporation
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expense
7.3.5 Recent strategies and developments:
7.3.5.1 Product Launches and Product Expansions:
7.3.5.2 Acquisition and Mergers:
7.3.6 SWOT Analysis
7.4 MicroPort Scientific Corporation
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.4.5 SWOT Analysis
7.5 Johnson & Johnson
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental & Regional Analysis
7.5.4 Research & Development Expenses
7.5.5 Recent strategies and developments:
7.5.5.1 Partnerships, Collaborations, and Agreements:
7.5.5.2 Product Launches and Product Expansions:
7.5.6 SWOT Analysis
7.6 B. Braun Melsungen AG
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expenses
7.6.5 SWOT Analysis
7.7 Integra LifeSciences Holdings Corporation
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expenses
7.7.5 SWOT Analysis
7.8 Delta Surgical
7.8.1 Company Overview
7.9 Penumbra, Inc.
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental and Regional Analysis
7.9.4 Research & Development Expenses

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings